In the BioHarmony Drug Report Database
Pamidronate
Aredia, Pamidronate Disodium (pamidronic acid) is a small molecule pharmaceutical. Pamidronic acid was first approved as Aredia on 1991-10-31. It is used to treat extramammary paget disease, hypercalcemia, osteolysis, and postmenopausal osteoporosis in the USA. The pharmaceutical is active against farnesyl pyrophosphate synthase.
Trade Name
|
Aredia, Pamidronate Disodium |
|---|---|
Common Name
|
pamidronic acid |
ChEMBL ID
|
CHEMBL834 |
Indication
|
extramammary paget disease, hypercalcemia, osteolysis, postmenopausal osteoporosis |
Drug Class
|
Calcium metabolism regulators |
Image (chem structure or protein)